Market Research Reports, Business Consulting Services & Analytics

Growing Awareness of the Condition and New Drugs in the Market Have Aided the Evolution of the Human Growth Hormone Market

HYDERABAD, TELANGANA, INDIA, January 10, 2023 /EINPresswire.com/ -- The Global Human Growth Hormone market is estimated to grow at a CAGR of 7.44% during the forecast period 2019–2025. The market is projected to grow from $4,253.6 Million to $7,003.11 Million by 2025. Human Growth Hormones are drugs made with the combination of various synthetically prepared substances that provide the body with Human Growth Hormones (HGH)HGH is also called somatotropin. HGH helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Human Growth Hormones drugs are used when peptide hormones, responsible for stimulating growth hormones are unable to function properly. Placental lactogen (PL) and growth hormone (GH) are pituitary hormones that regulate a wide-ranging variety of important physical functions. Parents and millennials have recognized the prevalence of human growth disorders. Previously, these conditions were left ignored. But, the recent awareness and new drugs in the market have aided the evolution of the human growth hormone market.

Click here to browse the complete report summary:
https://www.industryarc.com/Report/16859/human-growth-hormone-market.html

Key Takeaways

1. In the coming years, growing interest in Human Growth Hormone is due to the rising awareness of the medical condition between parents as well as Millennials.

2. Product launch was a key sustainability strategy adopted by the market players to ensure the growth of the Human Growth Hormone market.

3. APAC region is estimated to record the fastest growth rate during the forecast period.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=16859

Segment Analysis

1. Growth Hormone Deficiency (GHD) segment dominated the Human Growth Hormone Market in terms of revenue. It is forecast to grow at a CAGR of 6.85% during the period under consideration. Growth Hormone Deficiency is caused by anterior pituitary disorder, metabolic disorder, tumours in the pituitary gland and other reasons.

2. The Subcutaneous segment dominated the Human Growth Hormone market in 2018. The subcutaneous tissue layer of the skin has close contact with the muscles and tends to house the majority of the body’s growth hormones. Amino acids such as arginine, lysine and ornithine can stimulate growth hormones when administered orally.

3. The Hospital Pharmacies segment dominated the market in terms of revenue. As Human Growth Hormones are medicines prescribed by doctors, patients tend to purchase them from hospital pharmacies to ensure an appropriate cure.

4. The North America region occupied 48% of the global Human Growth Hormone market in terms of revenue. The Human Growth Foundation says that in the U.S., approximately one in 4,000 to 10,000 children has GHD, and approximately 50,000 adults have GHD, with about 6,000 new adult patients diagnosed every year. APAC region is estimated to record the fastest growth rate during the forecast period.

Competitive Landscape:

The top 5 players in the Human Growth Hormone Market Industry are -

1. Teva Pharmaceutical Industries Ltd
2. Pfizer Inc.
3. Novo Nordisk A/S
4. Ipsen
5. Ferring BV

Click on the following link to buy the Human Growth Hormone Market Report:
https://www.industryarc.com/reports/request-quote?id=16859

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.

Related Reports:

A. Hormonal Contraception Market
https://www.industryarc.com/Report/15879/hormonal-contraception-market.html

B. Hormone Replacement Therapy Market
https://www.industryarc.com/Report/15880/hormone-replacement-therapy-market.html

Contact Us:
Mr Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+1 614-588-8538
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.